BRAIDWELL LP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BRAIDWELL LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$109,764,480
+8.6%
114,338,000
-10.9%
3.47%
+5.0%
Q2 2023$101,094,132
-4.8%
128,338,000
-10.5%
3.30%
-5.7%
Q1 2023$106,213,458
+66.8%
143,338,000
+1.3%
3.50%
+64.2%
Q4 2022$63,675,000141,500,0002.13%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 141,500,000$63,675,0002.13%
ARISTEIA CAPITAL, L.L.C. 156,841,000$70,578,4501.41%
Affinity Asset Advisors, LLC 7,500,000$3,410,0481.34%
CONTRARIAN CAPITAL MANAGEMENT, L.L.C. 8,500,000$3,782,5000.94%
TFG Asset Management GP Ltd 10,000,000$4,623,6110.66%
Context Capital Management, LLC 17,035$7,8900.58%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 47,329,000$18,8130.52%
SILVERBACK ASSET MANAGEMENT LLC 5,000,000$2,287,8500.32%
MACKAY SHIELDS LLC 14,611,000$6,574,9500.17%
Ionic Capital Management LLC 1,400,000$644,7400.15%
View complete list of BRIDGEBIO PHARMA INC shareholders